Table 1.
Study population characteristics
| Age (years) | 82.5 ± 6.2 |
| Male/female | 64/51 |
| BMI (kg m−2) | 26.7 ± 3.6 |
| BSA (m2) | 1.79 ± 0.16 |
| Baseline creatinine (mg dl−1) | 1.19 ± 0.43 |
| HR (beats/min) | 67.7 ± 11.1 |
| LVEF (%) | 49 ± 6.6 |
| Aortic valve gradient (max) | 74.6 ± 7.3 |
| Atrial fibrillation | 15/115 |
| Patients with previous coronary stenting, n | 17 |
| Stent number | 49 |
| Drug-eluting stent, n | 44 |
| Bare-metal stent, n | 5 |
| Patients with previous CABG, n | 7 |
| CABG n | 16 |
| Cardiovascular risk factors: | |
| Hypertension, n | 82 |
| Hypercholesterolemia, n | 79 |
| Diabetes mellitus, n | 21 |
| Current smoking, | 8 |
| Family history of CAD, n | 84 |
| Implanted valve (n) | 115 |
BMI, body mass index; BSA, body surface area; CABG, coronary arteries by pass grafting mark; HR, heart rate; LVEF, left ventricle ejection fraction; PCI, percutaneous coronary intervention.